KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Palvella Therapeutics (PVLA) Revenue: 2014-2024

Historic Revenue for Palvella Therapeutics (PVLA) over the last 11 years, with Dec 2024 value amounting to -$181,000.

  • Palvella Therapeutics' Revenue fell 113.93% to -$181,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $951,000, marking a year-over-year decrease of 97.78%. This contributed to the annual value of -$430,000 for FY2024, which is 101.00% down from last year.
  • Latest data reveals that Palvella Therapeutics reported Revenue of -$181,000 as of Q4 2024, which was up 17.73% from -$220,000 recorded in Q3 2024.
  • In the past 5 years, Palvella Therapeutics' Revenue ranged from a high of $20.1 million in Q2 2023 and a low of -$220,000 during Q3 2024.
  • Its 3-year average for Revenue is $6.2 million, with a median of $3.7 million in 2022.
  • As far as peak fluctuations go, Palvella Therapeutics' Revenue surged by 443.16% in 2023, and later crashed by 113.93% in 2024.
  • Over the past 5 years, Palvella Therapeutics' Revenue (Quarterly) stood at $1.9 million in 2020, then soared by 349.81% to $8.4 million in 2021, then tumbled by 30.76% to $5.8 million in 2022, then plummeted by 77.78% to $1.3 million in 2023, then crashed by 113.93% to -$181,000 in 2024.
  • Its Revenue stands at -$181,000 for Q4 2024, versus -$220,000 for Q3 2024 and $53,000 for Q1 2024.